Skip to main content
. 2020 May 11;40(5):BSR20193410. doi: 10.1042/BSR20193410

Figure 5. Plasma IL-6, IL-10 and TNF-α concentrations between the groups.

Figure 5

Changes in plasma (A) interlukin-6 (IL-6), (B) interlukin-10 (IL-10), and (C) tumor necrosis factor-α (TNF-α) levels in patients receiving dexmedetomidine or saline. Values are expressed as means ± SEM.